Features

Native American people are disproportionately underemployed in science fields. We're hoping to change that.

Learn how veterans enrich our culture of innovation.

Get some key highlights of our performance this quarter.

The WATCHMAN Left Atrial Appendage Closure device has given one employee's family more time to celebrate.

CAD is the most common form of heart disease. Learn why arteries become clogged and how minimally invasive treatments can reopen them.

It's all part of our goal to achieve net-zero greenhouse gas emissions across our value chain by 2050.

Get some key highlights of our performance this quarter.

Grants from the Boston Scientific Foundation are helping young people to succeed at STEM — and in life.

These therapies can alleviate the debilitating symptoms of incontinence and overactive bladder.

Learn how AI technology is helping patients with heart failure and dangerous arrythmias.

Research scientist Changfang Zhu shares what she's learned after moving from China to the U.S.

Get some key highlights of our performance this quarter.

It's allowed more than 1,500 employees worldwide to advance their careers while staying at Boston Scientific.

Learn about endoscopic sleeve gastroplasty (ESG) and the gastric balloon.

And thanks to a Boston Scientific device, Cathy's future should remain stroke-free.

Get some key highlights of our performance this quarter.

One in five people will develop cancer in their lifetimes. Learn about our innovative treatment options.

Learn how it will help us reach more women with overactive bladder and other debilitating urological conditions.

Our site in Kerkrade, the Netherlands, shows how our renewable energy strategy is paying off.

Learn how the pump, and penile prosthesis implants, work.

Turning a great idea into reality doesn’t happen in a vacuum. It requires a strong company culture.

This acquisition will enable us to reach more of the millions of people at risk of stroke around the world. Learn how.

Get some key highlights of our performance this quarter.

A precision approach kills cancer cells while minimizing side effects, often in one outpatient procedure.

Grants from the Boston Scientific Foundation are helping health-focused nonprofits, and their clients, to thrive.